← Back to Screener
Baxter International Inc. (BAX)
Price$18.40
Value ScoreB
Growth ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-8.12%
Price vs S&P 500 (4W)4.15%
VGM Score44.20
Market Capitalization$9.55B
Indicated Dividend Yield (Annual)0.21%
All Metrics
P/CF (Annual)11.30x
Book Value / Share (Quarterly)$11.70
P/TBV (Annual)5.58x
Indicated Dividend (Annual)$0.04
Revenue Growth (3Y)-9.39%
Cash Flow / Share (Quarterly)$1.40
Payout Ratio (TTM)90.20%
Price vs S&P 500 (YTD)-12.66%
Gross Margin (TTM)30.69%
Net Profit Margin (TTM)-9.70%
EPS (TTM)$-2.14
10-Day Avg Trading Volume6.74M
EPS Excl Extra (TTM)$-2.14
Revenue Growth (5Y)-0.75%
EPS (Annual)$-1.87
Dividend / Share (Annual)$0.68
ROI (Annual)-6.13%
Gross Margin (Annual)30.68%
Net Profit Margin (5Y Avg)-0.55%
Cash / Share (Quarterly)$3.91
Revenue Growth QoQ (YoY)2.90%
ROA (Last FY)-4.77%
Revenue Growth TTM (YoY)-4.79%
EBITD / Share (TTM)$-0.17
ROE (5Y Avg)-4.18%
Operating Margin (TTM)-2.55%
Cash Flow / Share (Annual)$0.65
P/B Ratio1.58x
P/B Ratio (Quarterly)1.44x
Net Income / Employee (Annual)$-25,500
EV / Revenue (TTM)1.50x
Net Interest Coverage (TTM)-0.91x
ROA (TTM)-5.36%
EV / EBITDA (TTM)89.94x
EPS Incl Extra (Annual)$-1.87
Current Ratio (Annual)2.31x
Quick Ratio (Quarterly)1.03x
3-Month Avg Trading Volume8.92M
52-Week Price Return-38.83%
EV / Free Cash Flow (Annual)51.20x
Revenue / Employee (TTM)$301,900
Tangible BV / Share (Quarterly)$3.53
P/S Ratio (Annual)0.85x
Asset Turnover (Annual)0.56x
52-Week High$32.04
Operating Margin (5Y Avg)0.22%
EPS Excl Extra (Annual)$-1.87
CapEx CAGR (5Y)-6.27%
Tangible BV CAGR (5Y)-22.78%
26-Week Price Return7.81%
Quick Ratio (Annual)1.48x
13-Week Price Return-7.76%
Total Debt / Equity (Annual)1.55x
Current Ratio (Quarterly)1.85x
Enterprise Value$17.00B
Revenue / Share Growth (5Y)-0.59%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)-7.08%
Revenue / Employee (Annual)$299,800
Inventory Turnover (Annual)3.64x
Pretax Margin (Annual)-4.49%
Cash / Share (Annual)$3.82
3-Month Return Std Dev40.60%
Gross Margin (5Y Avg)34.63%
Net Income / Employee (TTM)$-29,300
EBITDA CAGR (5Y)-31.69%
EBITDA Interim CAGR (5Y)-28.68%
ROE (Last FY)-15.61%
Net Interest Coverage (Annual)-0.93x
EPS Basic Excl Extra (Annual)$-1.87
P/FCF (TTM)13.21x
Receivables Turnover (TTM)6.53x
EV / Free Cash Flow (TTM)23.51x
Total Debt / Equity (Quarterly)1.57x
EPS Incl Extra (TTM)$-2.14
Receivables Turnover (Annual)6.14x
ROI (TTM)-6.79%
Dividend Growth Rate (5Y)-6.21%
P/S Ratio (TTM)0.84x
Pretax Margin (5Y Avg)-1.92%
Revenue / Share (Annual)$21.92
Tangible BV / Share (Annual)$3.42
Forward P/E9.68x
Free OCF CAGR (5Y)-22.12%
Price vs S&P 500 (52W)-67.03%
Year-to-Date Return-1.73%
5-Day Price Return-2.09%
EPS Normalized (Annual)$-1.87
ROA (5Y Avg)-0.53%
Net Profit Margin (Annual)-8.51%
Month-to-Date Return6.83%
Cash Flow / Share (TTM)$2.60
EBITD / Share (Annual)$-0.19
Operating Margin (Annual)-2.64%
LT Debt / Equity (Annual)1.54x
P/CF (TTM)7.64x
ROI (5Y Avg)-0.69%
LT Debt / Equity (Quarterly)1.43x
EPS Basic Excl Extra (TTM)$-2.14
P/TBV (Quarterly)4.75x
P/B Ratio (Annual)1.60x
Dividend / Share (TTM)$0.52
Inventory Turnover (TTM)3.50x
Pretax Margin (TTM)-4.49%
Book Value / Share (Annual)$11.92
Price vs S&P 500 (13W)-17.51%
Dividend Yield (TTM)2.78%
Beta0.64x
P/FCF (Annual)28.77x
Revenue / Share (TTM)$21.98
ROE (TTM)-16.43%
52-Week Low$15.73
vGradeB
gGradeF
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.36est. 0.31
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.76
3.23
3.23
3.23
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BAXBaxter International Inc. | B | F | C | $18.40 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Baxter supplies medical devices and therapies to hospitals and care settings, including injectable products, IV systems, nutritional solutions, and surgical sealants. The company expanded its hospital equipment portfolio through its 2021 Hillrom acquisition and divested its kidney care business in early 2025.